Kate Secombe

Expand

• Appointments

  Date	Position	Institution name
  2014 - 2016	Technical Assistant	University of Adelaide

• Awards and Achievements

  Date	Type	Title	Institution Name	Country	Amount
  2020	Award	Young Scientist, 70th Lindau Nobel Laureate Meeting	Australian Academy of Science	Australia	—
  2020	Fellowship	Adam J Berry Fellowship Awardee	Australian Academy of Science and National Insititutes of Health (USA)	United States	—
  2019	Award	Outstanding Community Presentation, RAHsearch Showcase	Royal Adelaide Hospital	Australia	—
  2019	Award	CSIRO ON Pitch Competition, 2nd place	CSIRO	Australia	—
  2019	Honour	Falling Walls Australia, 2nd place	Australian Academy of Science	Australia	—
  2018	Award	Hans-Jürgen and Maria Ohff Research Grant	University of Adelaide	Australia	—
  2017	Scholarship	Lions Medical Research Foundation Inc Scholarship	The University of Adelaide	—	—
  2017	Award	Lions Medical Research Foundation Inc Travel Grant	—	—	—
  2017	Scholarship	Research Training Program Stipend	University of Adelaide	Australia	—
  2014	Achievement	Highest Honours Grade	—	—	—
  2014	Achievement	Best Honours Poster Presentation	—	—	—
  2013	Award	Faculty of Sciences Outstanding Academic Achievement	—	—	—
  2012	Award	Faculty of Sciences Outstanding Academic Achievement	—	—	—

• Education

  Date	Institution name	Country	Title
  2017	University of Adelaide	Australia	PhD in Medicine
  2014 - 2014	University of Adelaide	Australia	Bachelor of Health Sciences (Honours)
  2010 - 2014	University of Adelaide	Australia	Bachelor of Science (Biomedical Science)

Expand

• Journals

  Year	Citation
  2020	Secombe, K. R., Van Sebille, Y. Z. A., Mayo, B. J., Coller, J. K., Gibson, R. J., & Bowen, J. M. (2020). Diarrhea Induced by Small Molecule Tyrosine Kinase Inhibitors Compared With Chemotherapy: Potential Role of the Microbiome.. Integr Cancer Ther, 19, 1534735420928493. DOI
  2020	Secombe, K. R., Ball, I. A., Shirren, J., Wignall, A. D., Keefe, D. M., & Bowen, J. M. (2020). Pathophysiology of neratinib-induced diarrhea in male and female rats: microbial alterations a potential determinant. Breast Cancer, 11 pages. DOI
  2020	Mayo, B., Secombe, K., Wignall, A., Bateman, E., Thorpe, D., Pietra, C., . . . Bowen, J. (2020). The GLP-2 Analogue Elsiglutide Reduces Diarrhoea Caused by the Tyrosine Kinase Inhibitor Lapatinib in Rats. Cancer Chemotherapy and Pharmacology, 85(4), 793-803. DOI Scopus1 WoS2 Europe PMC1
  2019	Secombe, K. R., Coller, J. K., Gibson, R. J., Wardill, H. R., & Bowen, J. M. (2019). The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy‐induced gastrointestinal toxicity. International Journal of Cancer, 144(10), 2365-2376. DOI Scopus11 WoS11 Europe PMC3
  2019	Secombe, K., Ball, I., Shirren, J., Wignall, A., Finnie, J., Keefe, D., . . . Bowen, J. (2019). Targeting neratinib-induced diarrhea with budesonide and colesevelam in a rat model. Cancer Chemotherapy and Pharmacology, 83(3), 531-543. DOI Scopus3 WoS4 Europe PMC2
  2019	Wardill, H., Secombe, K., Bryant, R., Hazenberg, M., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740. DOI Scopus11 WoS10 Europe PMC7
  2017	Coller, J., Bowen, J., Ball, I., Wardill, H., Van Sebille, Y., Stansborough, R., . . . Gibson, R. (2017). Potential safety concerns of TLR4 antagonism with irinotecan: a preclinical observational report. Cancer Chemotherapy and Pharmacology, 79(2), 431-434. DOI Scopus5 WoS5 Europe PMC1
  2017	Van Sebille, Y., Gibson, R., Wardill, H., Secombe, K., Ball, I., Keefe, D., . . . Bowen, J. (2017). Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats. International Journal of Cancer, 140(12), 2820-2829. DOI Scopus13 WoS11 Europe PMC8
  2016	Wardill, H., Gibson, R., Van Sebille, Y., Secombe, K., Logan, R., & Bowen, J. (2016). A novel in vitro platform for the study of SN38-induced mucosal damage and the development of Toll-like receptor 4-targeted therapeutic options. Experimental Biology and Medicine, 241(13), 1386-1394. DOI Scopus6 WoS6 Europe PMC4
  2016	Wardill, H., Gibson, R., Van Sebille, Y., Secombe, K., Coller, J., White, I., . . . Bowen, J. (2016). Irinotecan-induced gastrointestinal dysfunction and pain are mediated by common TLR4-dependent mechanisms. Molecular Cancer Therapeutics, 15(6), 1376-1386. DOI Scopus42 WoS37 Europe PMC16
  2016	Wardill, H., Bowen, J., Van Sebille, Y., Secombe, K., Coller, J., Ball, I., . . . Gibson, R. (2016). TLR4-dependent claudin-1 internalization and secretagogue-mediated chloride secretion regulate irinotecan-induced diarrhea. Molecular Cancer Therapeutics, 15(11), 2767-2779. DOI Scopus14 WoS16 Europe PMC9

• Conference Papers

  Year	Citation
  2019	Bowen, J. M., Secombe, K. R., Ball, I. A., Shirren, J., Wignall, A. D., Finnie, J. W., . . . Keefe, D. (2019). Budesonide and colesevelam reduce neratinib-induced diarrhea in a rat model. In CANCER RESEARCH Vol. 79 (pp. 2 pages). San Antonio, TX: AMER ASSOC CANCER RESEARCH. DOI
  2019	Bruning, E., Coller, J., Wardill, H., Secombe, K., & Bowen, J. (2019). Toll-like receptor 4 humanized C57BL/6 mouse intestinal permeability: A translational model for cancer treatment toxicity. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 34 (pp. 166). WILEY.
  2019	Secombe, K., Bowen, J., Ball, I., Shirren, J., Wignall, A., Lalani, A., & Diala, I. (2019). The gut microbiome as an intervention target for neratinib-induced diarrhoea. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 15 (pp. 107-108). WILEY.
  2018	Wardill, H., Secombe, K., Gibson, R., Stringer, A., Al-Dasooqi, N., Mayo, B., & Bowen, J. (2018). Pre-treatment blautia abundance regulates chemo-toxicity in colorectal cancer patients: A pilot study. In NEUROGASTROENTEROLOGY AND MOTILITY Vol. 30 (pp. 1 page). WILEY.
  2018	Secombe, K., Bowen, J., Coller, J., Gibson, R., Stringer, A., Al-Dasooqi, N., . . . Wardill, H. R. (2018). Pre-treatment Blautia abundance regulates chemotherapy-induced gastrointestinal toxicity risk: a pilot study. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY Vol. 14 (pp. 59). WILEY. WoS1

• Conference Items

  Year	Citation
  2017	Secombe, K. R., Ball, I. A., Shirren, J., Wignall, A. D., Wardill, H. R., Van Sebille, Y. Z. A., & Bowen, J. M. (2017). Budesonide Reduces Neratinib-Induced Gastrointestinal Injury and Diarrhoea in Rats. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. WoS1

Practical Demonstrator

Physiology IIA and IIB

Human Anatomy and Physiology IB

Teaching Assistant

Precision Medicine
Guest Lecturer

Integrative Cell Biology

Biology of Disease II

Online Tutor

Foundations of Human Biology, University of South Australia

Expand

• Memberships

  Date	Role	Membership	Country
  2016 - ongoing	Member	Multinational Association for Supportive Care in Cancer	—
  2014 - ongoing	Member	Australian Society of Medical Research	—
  2013 - ongoing	Board Member	Faculty of Sciences Board	—
  2011 - ongoing	—	Golden Key International Honour Society	—

• Phone: 83131537
• Email: kate.secombe@adelaide.edu.au
• Campus: North Terrace
• Building: Helen Mayo South, floor 2
• Org Unit: Faculty of Health and Medical Sciences